Intocell is Drug Discovery in South Korea that focus on platform focus business. Founded in 2015. They cover business area such as developer, biotechnology platform, antibody-drug conjugate, commercialization, novel adc, scaffold moiety, ligand, toxin, linker, conjugation method, doctor, patient, disease, unmet medical need.
2015
( 9 years old in 2024 )
Platform Focus
-
101, Sinildong-ro
Daejeon, Daedeok-gu
South Korea
Private
developerbiotechnology platformantibody-drug conjugatecommercializationnovel adcscaffold moietyligandtoxinlinkerconjugation methoddoctorpatientdiseaseunmet medical need
* We use standard office opening hours in near Intocell's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Intocell is Drug Discovery business from South Korea that founded in 2015 (9 years old in 2024), Intocell business is focusing on Platform Focus.
Intocell headquarter office and corporate office address is located in 101, Sinildong-ro Daejeon, Daedeok-gu South Korea.
Intocell was founded in South Korea.
In 2024, Intocell is currently focus on platform focus sector.
Above is snippet of Google Trends for "platform focus" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Intocell, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
